TOP GUIDELINES OF CONOLIDINE PROLEVIATE FOR JOINT PAIN TREATMENT

Conolidine’s analgesic outcomes stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors during the central nervous process, conolidine modulates alternate molecular targets. A Science Advancements review discovered that conolidine interacts Along with the atypical chemokine receptor ACKR3/